Guillermo Lasarte-Aragones

Dr. Guillermo Lasarte-Aragones

Institute of Nanochemistry (IUNAN) Department of Analytical Chemistry University of Córdoba (Spain)
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in ACS Catalysis
Verified
Journal Article
Open access
Gregory EllisGregory Ellis
Gregory Ellis
WKWilliam P. Klein
William P. Klein
Guillermo Lasarte-AragonesGuillermo Lasarte-Aragones
Guillermo Lasarte-Aragones
MTMeghna Thakur
Meghna Thakur
Scott A. WalperScott A. Walper
Scott A. Walper
Igor MedintzIgor Medintz
Igor Medintz
Artificial multienzyme scaffolds are being developed for in vitro cascaded biocatalytic activity and, in particular, accessing substrate channeling. This review covers progress in this field over the last ∼5 years with a specific focus on the scaffold materials themselves and the benefits they can provide for assembling multienzyme cascades in vitro. These benefits include improving biocatalytic efficiency, bypassing potential cellular toxicity, directed catalysis, modularity, incorporating enzymes from different prokaryotic and eukaryotic sources, and potentially the ability to create de novo designer cascades. We begin with an overview of the strongest impetus currently driving the rapid development of this field, namely, biomanufacturing and cell-free synthetic biology. We then discuss in detail pertinent mechanisms responsible for the benefits of artificial multienzyme scaffolds. In particular, we focus on substrate channeling, including the evolving debate about what leads to substrate channeling in artificial systems─proximity, confinement, or both─and whether sequential enzyme order is really needed. How different scaffold materials/chemistries can in turn affect enzyme activity is also discussed. The bulk of the review then details progress in the development of different biotic (e.g., cells) and abiotic (e.g., nanoparticles) scaffolding materials and is divided up by class and subtype as needed. Within each material class of scaffolds, attention is given to their inherent chemical diversity, how they are engineered, how they allow for enzymatic attachment, their ease of use, their benefits (e.g., inherent three-dimensional architecture) and liabilities where appropriate, and other relevant issues. For each scaffolding material, a detailed overview of current progress is provided using examples of multienzyme cascades and data/schematics reproduced from the literature. Special attention is also given to the use of DNA scaffolds, as they can potentially provide the most versatile designer three-dimensional scaffold architectures. Finally, a short perspective on how this rapidly moving field will evolve in the near and long terms is provided.

6 August 2018 in ACS Sensors
Verified
Journal Article
Open access
Scott A. WalperScott A. Walper
Scott A. Walper
Guillermo Lasarte-AragonesGuillermo Lasarte-Aragones
Guillermo Lasarte-Aragones
KSKim E. Sapsford
Kim E. Sapsford
CBCarl W. Brown
Carl W. Brown
CRClare E. Rowland
Clare E. Rowland
Igor MedintzIgor Medintz
Igor Medintz
Although a fundamental understanding of the pathogenicity of most biothreat agents has been elucidated and available treatments have increased substantially over the past decades, they still represent a significant public health threat in this age of (bio)terrorism, indiscriminate warfare, pollution, climate change, unchecked population growth, and globalization. The key step to almost all prevention, protection, prophylaxis, post-exposure treatment, and mitigation of any bioagent is early detection. Here, we review available methods for detecting bioagents including pathogenic bacteria and viruses along with their toxins. An introduction placing this subject in the historical context of previous naturally occurring outbreaks and efforts to weaponize selected agents is first provided along with definitions and relevant considerations. An overview of the detection technologies that find use in this endeavor along with how they provide data or transduce signal within a sensing configuration follows. Current “gold” standards for biothreat detection/diagnostics along with a listing of relevant FDA approved in vitro diagnostic devices is then discussed to provide an overview of the current state of the art. Given the 2014 outbreak of Ebola virus in Western Africa and the recent 2016 spread of Zika virus in the Americas, discussion of what constitutes a public health emergency and how new in vitro diagnostic devices are authorized for emergency use in the U.S. are also included. The majority of the Review is then subdivided around the sensing of bacterial, viral, and toxin biothreats with each including an overview of the major agents in that class, a detailed cross-section of different sensing methods in development based on assay format or analytical technique, and some discussion of related microfluidic lab-on-a-chip/point-of-care devices. Finally, an outlook is given on how this field will develop from the perspective of the biosensing technology itself and the new emerging threats they may face.

1 January 2015 in Talanta
Verified
Journal Article
Closed access
Guillermo Lasarte-AragonesGuillermo Lasarte-Aragones
Guillermo Lasarte-Aragones
RLRafael Lucena
Rafael Lucena
SCSoledad Cárenas
Soledad Cárenas
MVMiguel Valcárcel
Miguel Valcárcel

1 January 2014 in Analytica Chimica Acta
Verified
Journal Article
Closed access
Guillermo Lasarte-AragonesGuillermo Lasarte-Aragones
Guillermo Lasarte-Aragones
RLRafael Lucena
Rafael Lucena
SCSoledad Cárenas
Soledad Cárenas
MVMiguel Valcárcel
Miguel Valcárcel


1 December 2011 in Journal of Chromatography A
Verified
Journal Article
Closed access
Guillermo Lasarte-AragonesGuillermo Lasarte-Aragones
Guillermo Lasarte-Aragones
RLRafael Lucena
Rafael Lucena
SCSoledad Cárenas
Soledad Cárenas
MVMiguel Valcárcel
Miguel Valcárcel